Chemotherapy-associated steatohepatitis in patients with colorectal cancer and surgery on hepatic metastasis: Clinical validation of a histopathological scoring system and preoperative risk assessment;Chemotherapieassoziierte Leberveränderungen bei Patienten mit kolorektalem Karzinom und operativer Entfernung von Lebermetastasen: Evaluierung eines histopathologischen Scores und Erhebung präoperativer Risikofaktoren

Zeitschrift fur Gastroenterologie

Volumn 49, Issue 10, 2011, Pages 1407-1411

  Kampfenkel, T ^a   Tischoff, I ^b   Bonhag, H ^a   Eckardt, M ^a   Schmiegel, W ^a,c,d   Tannapfel, A ^b   Reinacher Schick, A ^a,d   Viebahn, R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b INSTITUT FÜR PATHOLOGIE   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

CASH; chemotherapy; colorectal cancer; liver metastasis

Indexed keywords

AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; BILIRUBIN; OXALIPLATIN;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CHEMOTHERAPY ASSOCIATED STEATOHEPATITIS; COLORECTAL CANCER; DRUG INDUCED DISEASE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; PREOPERATIVE PERIOD; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 80053548454     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0031-1281749     Document Type: Article

References (15)

1. Reinacher-Schick A, Pohl M, Schmiegel W. Chemotherapy of colorectal cancer. Internist 2009 50 (11) 1239-52
2. Wieser M, Sauerland S, Arnold D et al. Perioperative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials. BMC Cancer 2010 21 (10) 309
3. Van Cutsem E, Köhne C H., Hitre E. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009 360 (14) 1408-1417
4. Tannapfel A, Reinacher-Schick A. Chemotherapy associated hepatotoxicity in the treatment of advanced colorectal cancer (CRC). Z Gastroenterol 2008 46 (5) 435-440 (Pubitemid 352016656)
5. Rubbia-Brandt L. Hepatic lesions induced by systemic chemotherapy for digestive cancer. Ann Pathol 2010 30 (6) 421-425
6. Rubbia-Brandt L, Audard V, Sartoretti P et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004 15 (3) 460-466 (Pubitemid 38444550)
7. Vauthey J N., Pawlik T M., Ribero D et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. JClin Oncol 2006 24 (13) 2065-2072 (Pubitemid 46622116)
8. Tamandl D, Klinger M, Eipeldauer S et al. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 2011 18 (2) 421-430
9. Nordlinger B, Sorbye H, Glimelius B. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008 371 (9617) 1007-1016 (Pubitemid 351392040)
10. Rubbia-Brandt L, Lauwers G Y., Wang H et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin- associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010 56 (4) 430-439
11. Pawlik T M., Olino K, Gleisner A LJ et al. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. Gastrointest Surg 2007 11 (7) 860-868
12. Brouquet A, Benoist S, Julie C et al. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 2009 145 (4) 362-371
13. Tannapfel A, Denk H, Dienes H P. et al. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 2011 458 (5) 511-523
14. Tannapfel A, Reinacher-Schick A, Flott-Rahmel B. Steatohepatitis after chemotherapy for colorectal liver metastases (CASH). Pathologe 18 Jun 2011 [Epub ahead of print]
15. Nakano H, Oussoultzoglou E, Rosso E et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008 247 (1) 118-124